Page last updated: 2024-10-22

anastrozole and Endolymphatic Stromal Myosis

anastrozole has been researched along with Endolymphatic Stromal Myosis in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Anastrozole was effective to recurrent low-grade ESS even after being refractory to progestin therapy."1.37Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report. ( Ikeda, Y; Kawana, K; Kozuma, S; Nakagawa, S; Oda, K; Shoji, K; Takazawa, Y; Taketani, Y; Yasugi, T, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Friedlander, M1
Benson, C1
O'Connell, RL1
Reed, N1
Clamp, A1
Lord, R1
Millan, D1
Nottley, S1
Amant, F1
Steer, C1
Anand, A1
Mileshkin, L1
Beale, P1
Banerjee, S1
Bradshaw, N1
Kelly, C1
Carty, K1
Divers, L1
Alexander, L1
Edmondson, R1
Shoji, K1
Oda, K1
Nakagawa, S1
Kawana, K1
Yasugi, T1
Ikeda, Y1
Takazawa, Y1
Kozuma, S1
Taketani, Y1

Trials

1 trial available for anastrozole and Endolymphatic Stromal Myosis

ArticleYear
Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903).
    Gynecologic oncology, 2021, Volume: 161, Issue:1

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Endometrial Neoplasms; End

2021

Other Studies

1 other study available for anastrozole and Endolymphatic Stromal Myosis

ArticleYear
Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report.
    Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:3

    Topics: Adult; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; En

2011